Introduction to Emerging Therapies In Low Risk Mds
Let's dive into the details surrounding Emerging Therapies In Low Risk Mds. Panelists Vinod Pullarkat, MD; Ellen K. Ritchie, MD; Rami S. Komrokji, MD; and Thomas Prebet, MD, PhD, outline
Emerging Therapies In Low Risk Mds Comprehensive Overview
This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... This webinar will provide an overview on Session Chairs: Amy E. DeZern and Saskia Langemeijer EPO and Lenalidomide in
This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
Summary & Highlights for Emerging Therapies In Low Risk Mds
- Guillermo Garcia-Manero, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses
- Treatments
- This is a recording of a Zoom presentation that consultant haematologist Dr Beth Payne gave to the
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
- He dives into IPSS and IPSS-R scores, focused on helping patients to understand the meanings of high-risk and
That wraps up our extensive overview of Emerging Therapies In Low Risk Mds.
